CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases.
暂无分享,去创建一个
Haoran Jin | James A Koziol | Anne C Feng | J. Koziol | D. Fuller | A. Feng | Donald B Fuller | Haoran Jin
[1] J. Sylvester,et al. Prostate brachytherapy seed identification on post-implant TRUS images. , 2003, Medical physics.
[2] J. Roy,et al. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. , 1995, International journal of radiation oncology, biology, physics.
[3] R. Stock,et al. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. , 2003, Brachytherapy.
[4] D. Beyer,et al. Real-time optimized intraoperative dosimetry for prostate brachytherapy: a pilot study. , 2000, International journal of radiation oncology, biology, physics.
[5] W. Butler,et al. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation. , 2000, Techniques in urology.
[6] W. Lee,et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. , 2000, International journal of radiation oncology, biology, physics.
[7] A. Renshaw,et al. Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .
[8] H H Holm,et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. 1983. , 1983, The Journal of urology.
[9] Y. Yamada,et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. , 2003, International journal of radiation oncology, biology, physics.
[10] J. Koziol,et al. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. , 2004, Brachytherapy.
[11] S. Pathak,et al. Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry. , 2002, International journal of radiation oncology, biology, physics.
[12] A. D'Amico,et al. Optimizing target coverage by dosimetric feedback during prostate brachytherapy. , 2000, International journal of radiation oncology, biology, physics.
[13] P L Roberson,et al. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.
[14] J. Blasko,et al. Interstitial implantation techniques in prostate cancer , 1997, Journal of surgical oncology.
[15] W. Butler,et al. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy. , 2000, International journal of radiation oncology, biology, physics.
[16] Warren D D'Souza,et al. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability. , 2004, International journal of radiation oncology, biology, physics.
[17] W Cavanagh,et al. Palladium-103 brachytherapy for prostate carcinoma. , 2000, International journal of radiation oncology, biology, physics.
[18] Blasko,et al. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. , 2001, International journal of radiation oncology, biology, physics.
[19] Kent Wallner,et al. The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters. , 2003, Medical physics.
[20] Kenneth B. Thornton,et al. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology. , 2003, Brachytherapy.
[21] R. Stock,et al. Importance of post-implant dosimetry in permanent prostate brachytherapy. , 2002, European urology.